Versant Ventures versantventures.com

Versant Ventures is a healthcare investment firm committed to helping entrepreneurs build the healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $1.9 billion under management and offices in North America and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building.

Versant Ventures is a healthcare investment firm committed to helping entrepreneurs build the healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and developm...Show all

See All Exits Recent Exits

Phone: 415-801-8100

Fax: (650) 854-9513

One Sansome Street
Suite 3630
 San Francisco, 94104
 California, United States

Versant Ventures - Investments & Acquisitions

Show Real Data Versant Ventures Investments
See all Recent Investments
Date Company Round Amount Co-investors
2021-03-15Graphite BioSeries B$150MCormorant Asset Management, Deerfield Management, Federated Hermes, Fidelity Investments, Janus Henderson Investors, Logos Capital, OrbiMed Advisors, Perceptive Advisors, RA Capital Management, Rock Springs Capital, Samsara BioCapital, Surveyor Capital, and Venrock
2021-03-12Monte Rosa TherapeuticsSeries C$95MAisling Capital, Amzak Health, Avoro Capital Advisors, BlackRock, Cambridge Asset Management, Casdin Capital, Cormorant Asset Management, Fidelity Investments, Google Ventures, HBM Healthcare Investments, New Enterprise Associates, RTW Investments, Sixty Degree Capital, and T. Rowe Price
2021-03-03Century TherapeuticsSeries C$160MAvidity Partners, Casdin Capital, Federated Hermes, Fidelity Investments, Leaps by Bayer, Logos Capital, Marshall Wace Asset Management, Octagon Capital, OrbiMed Advisors, Qatar Investment Authority, and RA Capital Management
2021-02-24Vividion TherapeuticsSeries C$135MAcuta Capital, ARCH Venture Partners, Avoro Capital Advisors, BlackRock, Boxer Capital, BVF Partners, Casdin Capital, Driehaus Capital Management, Logos Capital, Mubadala Capital, Nextech Invest, RA Capital Management, SoftBank Group, Surveyor Capital, T. Rowe Price, and Woodline Partners
2021-02-11Pipeline TherapeuticsSeries C$80MBrace Pharma Capital, Casdin Capital, Franklin Templeton, Perceptive Advisors, Red Tree Venture Capital, Samsara BioCapital, Sectoral Asset Management, and Suvretta Capital Management
See all 5 investments